The CRISIS Study: A Randomized Open-label Study Assessing the Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Hospitalized Adults With Coronavirus-19 (COVID-19)
Latest Information Update: 18 Feb 2022
At a glance
- Drugs Brequinar (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms CRISIS
- Sponsors Clear Creek Bio
Most Recent Events
- 15 Jan 2021 Status changed from recruiting to completed.
- 01 Oct 2020 Planned End Date changed from 1 Oct 2020 to 1 Apr 2021.
- 01 Oct 2020 Planned primary completion date changed from 1 Sep 2020 to 1 Mar 2021.